“SGLT2 Inhibitors: Cardiorenal Mechanisms How a Glucose-Lowering Drug Became a Foundational Heart and Kidney Therapy”. Diabzen 4, no. 14 (July 7, 2026): 28–29. Accessed July 29, 2026. https://thediabzen.com/index.php/d/article/view/54.